STOCK TITAN

Inogen Inc - INGN STOCK NEWS

Welcome to our dedicated page for Inogen news (Ticker: INGN), a resource for investors and traders seeking the latest updates and insights on Inogen stock.

Inogen Inc. (INGN) is a pioneering medical technology company committed to enhancing the quality of life for supplemental oxygen users. Founded in 2001, Inogen emerged from a personal story of necessity and innovation. The company's mission began when Mae, the grandmother of one of the founders, was prescribed oxygen therapy, highlighting the need for more user-friendly and portable oxygen solutions. You can learn more about Mae's story here.

Inogen aims to revolutionize oxygen therapy technology, striving to keep pace with the active lifestyles of patients who rely on oxygen to lead fulfilling lives. The company estimates that over 2.5 million patients in the United States and more than 4.5 million patients worldwide use oxygen therapy.

The company's flagship product, the Inogen One system, is a compact, lightweight, and travel-approved portable oxygen concentrator designed to liberate patients from the constraints of heavy tanks, frequent refills, and stationary systems. This innovation provides patients with the freedom and independence to live their lives by moments, not by the minutes left in an oxygen tank.

Inogen's products and services are sold through various channels, including home medical equipment providers, distributors, large gas companies, and home oxygen providers. The company also rents its products directly to patients, generating the majority of its revenue within the United States.

Inogen's commitment to continuous improvement is evident in its ongoing projects and recent achievements. The company constantly works toward refining its product offerings and expanding its reach to benefit more patients globally.

Rhea-AI Summary
Inogen, Inc. (NASDAQ: INGN) appoints Kevin Smith as President and CEO, bringing over 20 years of medical device industry experience, aiming to drive growth and organizational transformation. The company reaffirms its full year financial guidance and announces its non-attendance at upcoming healthcare conferences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.21%
Tags
management
-
Rhea-AI Summary
Inogen, Inc. (INGN) to present at Stifel 2023 Healthcare Conference and Piper Sandler 35th Annual Healthcare Conference. The live webcast will be available on the Inogen Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.68%
Tags
conferences
-
Rhea-AI Summary
Inogen, Inc. (Nasdaq: INGN) Announces Q3 2023 Financial Results, Reports $84.0 Million in Total Revenue, a 20.3% Decrease from Q3 2022
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.14%
Tags
Rhea-AI Summary
Inogen, Inc. will report Q3 2023 financial results on November 7, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.8%
Tags
conferences earnings
-
Rhea-AI Summary
Inogen completes acquisition of Physio-Assist, expanding respiratory portfolio with Simeox device for bronchiectasis treatment. Acquisition expected to be immaterial to 2023 revenue and immediately accretive to gross margin. Simeox has CE mark in EU and is being sold in Europe, Asia, and Middle East. Inogen to pursue US regulatory approvals. Acquisition may provide access to large US market with 400,000 to 490,000 bronchiectasis patients. Transaction expected to be accretive to adjusted earnings starting in 2027.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
-
News
Rhea-AI Summary
Inogen appoints Mike Sergesketter as Interim CFO and reaffirms 2023 financial guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.6%
Tags
-
Rhea-AI Summary
Inogen, Inc. (Nasdaq: INGN) introduces the Rove 6™ portable oxygen concentrator in the US with an 8-year expected service life, extending to Inogen One® G5. The Rove 6 offers 6 settings, the longest battery life in the market, and delivers up to 1,260 mL/minute of medical grade oxygen at a weight of 4.8 pounds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.01%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
conferences

FAQ

What is the current stock price of Inogen (INGN)?

The current stock price of Inogen (INGN) is $11.96 as of February 4, 2025.

What is the market cap of Inogen (INGN)?

The market cap of Inogen (INGN) is approximately 272.0M.

What does Inogen Inc. do?

Inogen Inc. develops and manufactures portable oxygen concentrators to deliver oxygen therapy for patients with chronic respiratory conditions.

What is Inogen's flagship product?

Inogen's flagship product is the Inogen One system, a compact and lightweight portable oxygen concentrator.

How does Inogen sell its products?

Inogen sells its products through home medical equipment providers, distributors, large gas companies, and home oxygen providers. They also rent products directly to patients.

Where does Inogen generate most of its revenue?

Inogen generates the majority of its revenue in the United States.

How many patients use oxygen therapy according to Inogen?

Inogen estimates that more than 2.5 million patients in the United States and over 4.5 million patients worldwide use oxygen therapy.

What makes Inogen's products stand out?

Inogen's products, like the Inogen One system, are designed to be compact, lightweight, and travel-approved, freeing patients from heavy tanks and stationary systems.

What is the mission of Inogen Inc.?

Inogen's mission is to improve the quality of life for supplemental oxygen users by providing innovative and user-friendly oxygen therapy solutions.

Who inspired the founding of Inogen?

Inogen was inspired by Mae, the grandmother of one of the founders, who was prescribed oxygen therapy and needed a more convenient solution.

Where can I learn more about Inogen's history?

You can learn more about Inogen's history and inspiration behind its founding on their website at http://www.inogen.com/about-inogen/meet-mae/.

What is Inogen Inc.'s stock symbol?

Inogen Inc. is publicly traded with the stock symbol INGN.
Inogen Inc

Nasdaq:INGN

INGN Rankings

INGN Stock Data

272.02M
23.46M
1.8%
89.68%
3.2%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
GOLETA